Journal of Dental Anesthesia and Pain Medicine

  • 제23권6호
  • /
  • Pages.293-302
  • /
  • 2023
  • /
  • 2383-9309(pISSN)
  • /
  • 2383-9317(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지
DOI QR코드

DOI QR Code

A comparative review of epinephrine and phenylephrine as vasoconstrictors in dental anesthesia: exploring the factors behind epinephrine's prevalence in the US

  • 투고 : 2023.08.06
  • 심사 : 2023.11.04
  • 발행 : 2023.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This review paper delves into the comparative study of epinephrine and phenylephrine as vasoconstrictors in dental anesthesia, exploring their histories, pharmacological properties, and clinical applications. The study involved a comprehensive literature search, focusing on articles that directly compared the two agents in terms of efficacy, safety, and prevalence in dental anesthesia. Epinephrine, with its broad receptor profile, has been a predominant choice, slightly outperforming in the context of prolonging dental anesthesia and providing superior hemostasis, which is crucial for various dental procedures. However, the stimulation of beta-adrenergic receptors caused by epinephrine poses risks, especially to patients with cardiovascular conditions. Phenylephrine, a selective alpha-1 adrenergic agonist, emerges as a safer alternative for such patients, avoiding the cardiovascular risks associated with epinephrine. Moreover, its vasoconstrictive effect may not be as deleterious as that of epinephrine, due to its selective action. This review reveals that despite the potential benefits of phenylephrine, epinephrine continues to dominate in clinical settings, due to its historical familiarity, availability, and cost-effectiveness. The lack of commercially available pre-made phenylephrine dental carpules in most countries, except Brazil, and a knowledge gap within dental academia regarding phenylephrine, contribute to its limited use. This review concludes that while both agents are effective, the choice between them should be based on individual patient conditions, availability, and the practitioner's knowledge and familiarity with the agents. The underuse of other vasoconstrictors like levonordefrin and the unavailability of phenylephrine in pre-mixed dental cartridges in many countries highlights the need for further exploration and research in this field. Furthermore, we also delve into the role of levonordefrin and examine the rationale behind the exclusion of phenylephrine from commercially available pre-mixed local anesthetic carpules, suggesting a need for a responsive approach from pharmaceutical manufacturers to the distinct needs of the dental community.

키워드

참고문헌

  1. Ball C, Westhorpe R. Local anaesthetics-procaine (novocaine, ethocaine). Anaesth Intensive Care 2004; 32: 303-3.  https://doi.org/10.1177/0310057X0403200301
  2. Haas DA, Quinn CL. Local anesthesia. In: Pharmacology and therapeutics for dentistry. 7th ed. Edited by Mariotti AJ, Dowd FJ. Missouri, Elsevier. 2017, pp 206-20. Available from https://linkinghub.elsevier.com/retrieve/pii/B978032339307200014X 
  3. Hersh EV, Giannakopoulos H. Beta-adrenergic blocking agents and dental vasoconstrictors. Dent Clin North Am 2010; 54: 687-96.  https://doi.org/10.1016/j.cden.2010.06.009
  4. Kammerer PW, Seeling J, Alshihri A, Daublander M. Comparative clinical evaluation of different epinephrine concentrations in 4% articaine for dental local infiltration anesthesia. Clin Oral Investig 2014; 18: 415-21.  https://doi.org/10.1007/s00784-013-1010-7
  5. Molinoff PB. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs 1984; 28: 1-15.  https://doi.org/10.2165/00003495-198400282-00002
  6. Dalal R, Grujic D. Epinephrine [Updated 2023 May 1]. StatPearls [Internet]. 2023 Jan. Available from http://www.ncbi.nlm.nih.gov/books/NBK482160/ 
  7. Seminario-Amez M, Gonzalez-Navarro B, Ayuso-Montero R, Jane-Salas E, Lopez-Lopez J. Use of local anesthetics with a vasoconstrictor agent during dental treatment in hypertensive and coronary disease patients. A systematic review. J Evid Based Dent Pract 2021; 21: 101569. 
  8. Fischer J, Ganellin CR. Analogue-based drug discovery. Weinheim: Wiley-VCH. 2006. 
  9. Halling F, Neff A, Ziebart T. Local anesthetic usage among dentists: German and international data. Anesth Prog 2021; 68: 19-25.  https://doi.org/10.2344/anpr-67-03-12
  10. Godfrey MA. Comparison of length of anesthesia using the vasoconstrictors : epinephrine and phenylephrine with procaine, carbocaine, and lidocaine [Medical Doctor Thesis]. Omaha, NE, University of Nebraska medical center, 1964. Available from https://digitalcommons.unmc.edu/mdtheses/17. 
  11. Anestesico Lidocaina 2% com Fenilefrina Novocol - SS white (no date a) Pagina Inicial. Available from https://dentalmarket.com.br/periodontia-e-cirurgia/anestesicos/anestesico-lidocaina-2-com-fenilefrina-novocol---ss-white-sku200713 (Accessed: 27 February 2023). 
  12. DiBaise MD. Local anesthesia. In: Essential clinical procedures. 2nd ed. Edited by Dehn RW, Aspery DP. Philadelphia, Elsevier. 2007, pp 295-311. 
  13. Dunlevy TM, O'Malley TP, Postma GN. Optimal concentration of epinephrine for vasoconstriction in neck surgery. Laryngoscope 1996; 106: 1412-4.  https://doi.org/10.1097/00005537-199611000-00020
  14. Paterakis K, Schmitter M, Said Yekta-Michael S. Efficacy of epinephrine-free articaine compared to articaine with epinephrine (1:100 000) for maxillary infiltration, a randomised clinical trial. J Oral Rehabil 2018; 45: 467-75.  https://doi.org/10.1111/joor.12637
  15. Reed KL, Malamed SF, Fonner AM. Local anesthesia part 2: technical considerations. Anesth Prog 2012; 59: 127-36.  https://doi.org/10.2344/0003-3006-59.3.127
  16. Maniglia-Ferreira C, Almeida-Gomes F, Carvalho-Sousa B, Barbosa AVH, Lins CCSA, Souza FD, et al. Clinical evaluation of the use of three anesthetics in endodontics. Acta Odontol Latinoam AOL 2009; 22: 21-6. 
  17. Malamed SF. Handbook of local anesthesia. 7th ed. Missouri, Elsevier. 2019. 
  18. Gelotte CK, Zimmerman BA. Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers. Clin Drug Investig 2015; 35: 547-58.  https://doi.org/10.1007/s40261-015-0311-9
  19. Balakrishnan R, Ebenezer V. Contraindications of vasoconstrictors in dentistry. Biomed Pharmacol J 2013; 6: 409-14.  https://doi.org/10.13005/bpj/435
  20. Moore DC, Batra MS. The components of an effective test dose prior to epidural block. Anesthesiology 1981; 55: 693-6.  https://doi.org/10.1097/00000542-198155060-00018
  21. El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth 2018; 11: 35-44.  https://doi.org/10.2147/LRA.S154512
  22. Mackie K, Lam A. Epinephrine-containing test dose during beta-blockade. J Clin Monit 1991; 7: 213-6.  https://doi.org/10.1007/BF01619262
  23. Pancaro C, Nasr VG, Paulus JK, Bonney I, Flores AF, Galper JB, et al. Phenylephrine as a simulated intravascular epidural test dose in pediatrics: a pilot study. Paediatr Anaesth 2013; 23: 502-9.  https://doi.org/10.1111/pan.12157
  24. On'Gele MO, Weintraub S, Qi V, Kim J. Local anesthetics, local anesthetic systemic toxicity (LAST), and liposomal bupivacaine. Clin Sports Med 2022; 41: 303-15.  https://doi.org/10.1016/j.csm.2021.12.001
  25. Liu SS, Ortolan S, Sandoval MV, Curren J, Fields KG, Memtsoudis SG, et al. Cardiac arrest and seizures caused by local anesthetic systemic toxicity after peripheral nerve blocks: should we still fear the reaper? Reg Anesth Pain Med 2016; 41: 5-21.  https://doi.org/10.1097/AAP.0000000000000329
  26. Weinberg G, Barron G. Local anesthetic systemic toxicity (LAST): not gone, hopefully not forgotten. Reg Anesth Pain Med 2016; 41: 1-2. https://doi.org/10.1097/AAP.0000000000000334